When Caduceus Software Systems (OTCBB:CSOC) first came on the scene last November, the stock was active and seeing highs of around 9 cents.
Today it is trading at just 0.003 which means that if we see highs of just half of what this stock did back in November then we will be sitting with 150% gains!
Read why we like CSOC and are encouraging you put this on your radar ASAP…
Only about one in every ten hospitals has made the transition to electronic medical records (EMR). Time is running short for hospitals and physicians to make the move as professionals and their related associates have been mandated by the federal government to abide by “meaningful use” of EMR by the end of 2014. What are EMR? Simply put, EMR are electronic versions of the old school paper medical logs that are kept every time a person sees a doctor. This includes things such as prescriptions, vaccinations, doctor visits, hospital visits, etc. The big benefit of EMR is that all the records are then accessible at any time, by any physician within an organization or by the patient via a secure location on the internet to ensure that any care provider is completely up to speed with the patient’s medical history. Electronic Health Records (EHR) are very similar, only they are an aggregate of electronic medical records that are gathered cumulatively across more than one health care organization and then managed by clinicians and staff involved with the individual’s care.
Most have known about the mandate as it was put forth several years ago, but many involved have been slow to make the shift, despite the government dolling-out $30 billion in incentives as encouragement. Slow or not, making the change is not an option; those not using EMR at the start of 2015 will be subject to penalties for non-compliance.
Ultimately, the use of EMR is part of a global trend shift towards the use of electronics as an even larger part of medical care. In Australia, the federal government is launching a new e-health system in July utilizing electronic prescriptions that it feels will drastically reduce errors. Despite some initial criticisms, the three hospital wards involved in the testing reported a dramatic reduction in errors between 57 and 66 percent. Point being that EMR/EHR and the use of the internet are proving to be far more efficient, cost-saving and potentially life-saving solutions.
Because of the procrastination of many providers to move towards the mandates, there is a huge upswing in the size of the electronic medical record industry set to happen over the next couple years. It’s just a matter of simple math. If only about 10 percent have transitioned at this point and 100 percent are mandated over the next three years, the space will soon mushroom as compliance is attained.
This leaves young, well-positioned companies in the catbird’s seat for growth. Companies such as Caduceus Software Systems Corp. (OTCBB:CSOC), a United Kingdom-based healthcare information company, offers technologies to general practitioners to convert from arcane software to efficient, modern software that today’s medical industry demands. The company specializes in developing an all-in-one solution for private practitioners and doctors. The “Caduceus” name itself, which is the word for the well-known insignia used by medical professionals, explains the all-encompassing benefits that the company provides.
Caduceus has strategically developed alliances with established innovators in the medical technology field to bolster expansion. Sygnit Corporation, a private firm headquartered in Indiana, serves as software advisor to Caduceus. Sygnit originally designed the software that is now exclusively licensed to Caduceus as its flagship Healthcare Information System Software, called “Caduceus MMS”. Although Caduceus intends to further develop the software with the addition of more modules to continually expand its uses, the product has undergone more than two years of R&D, been extensively tested and is hitting the market.
The Caduceus MMS Software represents a new breed of EHR and Electronic Medical Billing software that provides the medical community with a diverse arsenal of professional-grade data management systems, while ensuring that ease-of-implementation and cost of ownership do not daunt clients. Unlike the average stable of EHR software systems currently offered to the medical industry, Caduceus MMS starts right at the gate with both billing (remittance and transactional support) and appointment scheduling capabilities. This is its uncompromising hallmark.
Caduceus MMS offers a complete package with more to offer in its most basic deployment than several of its competitors. Not only does it come with an enormous library of information about illnesses, mediation and possible diagnoses, but it comes stacked with the ability to maintain a database of tens of thousands of ICD9 and ICD10 Fee-for-Service (treatment), diagnostic, facility and other vital codes and delivers them in an easy-to-understand categorical manner and a billing and encryption system that is unparalleled by industry peers. Without getting too “long in the tooth” and “techy” about the offerings of Caduceus MMS, that is a mere sampling of what the product can do.
“These features represent our dedication to providing rich and fulfilling functionality that all doctors and healthcare assistants want. We have a very clear roadmap for our development and from this we will know how to target sales and marketing,” says Derrick Gidden, President of Caduceus.
To immediately jump-start sales, Caduceus is giving free 30-day trials of the Caduceus MMS Software System to 1,000 specifically chosen customers in the United Kingdom. The company expects a minimum of 25 percent retention from the samplings to sign-on for the fully licensed version. The company has released Caduceus MMS v1.0 for UK practitioners, fully compatible with British terminology and other localization features. “This is another positive step toward carrying out our corporate business plan to compete in a global EMR market that is expected to grow from $4.355 Billion in 2009 to $9.957 Billion in 2015,” added Gidden.
Caduceus clearly has the technology in hand to capture market share in an already growing, but poised to explode industry. Because their knowledge base and partnership with Sygnit, the company is hitting on all cylinders by providing physicians with the full gamut of technologies for their practice to keep pace with today’s demanding and competitive markets. Moreover, both Electronic Health Records and Electronic Medical Records are accounted for with its offerings, giving it a competitive edge.
A lower trading volume stock, Caduceus is sneaking by the radar of the investment community at the moment. But, because shares are only carrying a price tag of less than 3 cents, the company has a miniscule market cap of less than $5 million; leaving it has substantial headroom for growth. It is for these reasons that we believe that Caduceus Software Systems Corp. (OTCBB:CSOC) probably won’t go unnoticed for much longer and encourage our members to promptly add it to their watchlists and begin their due diligence.
Remember, we always encourage you to do your own due diligence. The best way to begin your research is to review the company's website, latest press releases and always dig into their filings with the SEC.
Intelligent traders use Stop Loss Orders to protect their investments. We highly recommend you do the same and never allow greed to disrupt your strategy. Book your profits when you can!
Disclaimer: This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. MyBestStockAlerts.com is a wholly-owned subsidiary of MyBestStockAlerts, LLC. We have been compensated two thousand dollars from a non-controlling third party for CSOC advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. MyBestStockAlerts, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.